Dr. Anupama Narla, MD
Palo Alto, CA
16 Years of Experience
Who is Dr. Narla, Pediatric Hematologist-Oncologist in Palo Alto, CA?
Where did Dr. Narla go to medical school and complete their residency?
Residency: University Of California-San Francisco
Medical School: Perelman School of Medicine University of Pennsylvania
Is Dr. Narla board certified as a Pediatric Hematologist-Oncologist?
Yes, Dr. Anupama Narla, MD is board certified by the American Board of Pediatrics
What languages does Dr. Narla speak?
Dr. Narla and their clinical team can communicate with patients in the following languages:
- English
- Spanish
What conditions does a Pediatric Hematologist-Oncologist like Dr. Narla typically treat?
As a Pediatric Hematologist-Oncologist, conditions treated by Dr. Anupama Narla may include:
Please contact Dr. Narla's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Pediatric Hematologist-Oncologist like Dr. Narla typically perform?
As a Pediatric Hematologist-Oncologist, procedures performed by Dr. Anupama Narla may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Narla's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Narla accept my insurance?
Please contact Dr. Narla's office to confirm accepted insurance plans.
Where is Dr. Narla's office located?
Dr. Anupama Narla's Primary Practice
1000 Welch Rd Ste 300
Palo Alto, CA 94304
(650) 497-8953
Recognitions
Publications
The emerging importance of ribosomal dysfunction in the pathogenesis of hematologic disorders., 2014
Lelidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells, 2014
Diminutive somatic deletions in the 5q region lead to a phenotype atypical of classical 5q-syndrome, 2013
Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts, 2012
L-leucine improves the anemia and developmental defects associated with Diamond, 2012
Fulmint thrombotic microangiopathy in Pediatrics: Where diagnostic and therapeutic dilemmas meet, 2012
Coordite loss of a microR and protein-coding gene cooperate in the pathogenesis of 5q(-) syndrome, 2011
Translatiol medicine: ribosomopathies, 2011
Dexamethasone and lelidomide have distinct functiol effects on erythropoiesis, 2011
Neotal Enteroviral Sepsis, 2011
Diamond Blackfan Anemia Treatment: Past, Present, and Future, 2011
Haploinsufficiency for ribosomal protein genes causes selective activation of p53, 2011
Ribosome defects in disorders of erythropoiesis, 2011
Difficulty Measuring Methotrexate in a Patient with High-Dose Methotrexate-Induced Nephrotoxicity, 2010
Ribosomopathies: human disorders of ribosome dysfunction, 2010
Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia, 2009
Blood group antigens in health and disease, 2005
What is Dr. Narla's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Narla's National Provider Identifier (NPI) number is 1598923195.
What common questions do patients ask about Dr. Narla?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Narla